Leigh MacMillan Archive — Page 8 of 84

November 26, 2024

Novel genetics approach enhances discovery of disease risk genes

VUMC researchers applied the new approach to large GWAS datasets for breast, prostate and lung cancers, and three brain disorders.

By Leigh MacMillan
November 15, 2024

New radiation therapy approach for treating lung cancers

VUMC researchers tested a treatment combining immunotherapy and online adaptive radiotherapy, which is tailored to real-time tumor changes during the treatment plan.

By Mahima Sharma
November 15, 2024

Zinc deficiency promotes Acinetobacter lung infection: Study

The study findings point to the potential of interleukin-13 antibodies — approved for use in humans — as a treatment to protect against bacterial pneumonia in patients with zinc deficiency.

By Leigh MacMillan
November 12, 2024

GLP-1 medicines are focus of Discovery Lecture on Nov. 21

Daniel Drucker, MD, a pioneering scientist whose research contributed to the development of the blockbuster GLP-1 medicines used to treat diabetes and obesity, was listed by TIME magazine as one of the 100 Most Influential People of 2024.

By Leigh MacMillan
(iStock image)
November 8, 2024

In-clinic reconstruction of skin cancer defects costs less than OR procedures

Researchers analyzed 1,206 patient cases and found that OR reconstruction cases had a higher median baseline cost of $2,308 compared to $987 for clinic procedures.

By Kanchana Devanathan
November 8, 2024

People with schizophrenia show distinct brain activity when faced with conflicting information

Researchers introduce a biomarker to indicate whether someone is struggling with the inflexible thinking associated with the disorder.

By Joseph Caputo